Related Experiment Video
Updated: May 24, 2026
Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
Published on: June 17, 2015
High content screening for compounds that induce early stages of human embryonic stem cell differentiation
JooHyun Jee1, HeeKyoung Jeon, DongYoun Hwang
1CHA University, College of Life Science, 502 Ace bldg, Yatap-Dong, Bundang-gu, Seongnam-si, Gyeonggi-do, South Korea.
Abstract:
Embryonic stem cells, due to their self-renewal and pluripotency properties, can be used to repair damaged tissues and as an unlimited source of differentiated cells. Although stem cells represent an important opportunity for cell based therapy and small molecules screening (in the context of drug or target discovery) many drawbacks are still preventing their widespread use. One of the most significant limitations is related to the complexity, as well as the reliability, of current protocols driving stem cells into any homogeneously differentiated cellular population. In this respect there is a strong demand for molecular agents promoting differentiation and thereby enabling robust, efficient and safe production of differentiated cells. In order to identify novel molecules that enhance early stages of differentiation, we developed an image based high content screening (HCS) approach using human embryonic stem cells (hESC). In our approach, we took advantage of custom image mining software specifically adapted for the selection of stem cell differentiation agents and the rejection of false positive hits. As a proof of concept -3500 small molecules originating from commercial libraries were screened and a number of molecules of interests were identified. These molecules show stem cell differentiation properties comparable to the phenotypic signature obtained with the reference compound retinoic acid.
Insights
Researchers screened 3500 small molecules to find agents that enhance embryonic stem cell differentiation. Novel compounds were identified, offering a more reliable method for producing differentiated cells for therapy and drug discovery.
Area of Science:
- Stem cell biology
- Drug discovery
- Regenerative medicine
Background:
- Embryonic stem cells (ESCs) offer potential for tissue repair and drug screening due to self-renewal and pluripotency.
- Current protocols for differentiating ESCs into specific cell types are complex and unreliable, hindering therapeutic applications.
- There is a need for molecular agents to promote robust and efficient ESC differentiation.
Purpose of the Study:
- To identify novel small molecules that enhance early-stage differentiation of human embryonic stem cells (hESCs).
- To develop and validate a high-content screening (HCS) approach for discovering stem cell differentiation agents.
Main Methods:
- An image-based high-content screening (HCS) approach was employed using hESCs.
- Custom image mining software was utilized to identify differentiation agents and filter false positives.
- Approximately 3500 small molecules from commercial libraries were screened.
Main Results:
- Several novel small molecules demonstrating stem cell differentiation properties were identified.
- The efficacy of identified molecules was comparable to the reference compound retinoic acid.
- The HCS approach proved effective in identifying promising differentiation agents.
Conclusions:
- The developed HCS method provides a robust and efficient platform for discovering stem cell differentiation agents.
- Identified molecules hold potential for improving cell-based therapies and drug discovery pipelines.
- This approach addresses the limitations of current ESC differentiation protocols, paving the way for safer and more effective cell production.
More Related Videos
09:36High-Content Screening Differentiation and Maturation Analysis of Fetal and Adult Neural Stem Cell-Derived Oligodendrocyte Precursor Cell Cultures
Published on: March 10, 2021
07:18A Simple Method to Identify Kinases That Regulate Embryonic Stem Cell Pluripotency by High-throughput Inhibitor Screening
Published on: May 12, 2017
